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Virus with an unusual ability to adapt to
new vertebrate host species.
Negative-sense RNA genome, 12–
14 kb, in eight (IAV, IBV) or seven (ICV,
IDV) segments.
IAV, IBV, and ICV are highly
transmissible human respiratory
pathogens.
Global distribution. In temperate
climates, peaks in winter months.
Adaptation of new IAV strains to
humans causes pandemics.
Diverse IAV strains circulate in
waterfowl, often as asymptomatic
gastrointestinal infections.
DISEASE FACTS:
An acute infection. In humans, viral
shedding begins after around 1 day
and peaks before the onset of
symptoms.
Typical symptoms include sudden
onset of fever, muscle pain, headachesRNP NP Polymerase
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Key:
This infographic briefly summarises the natural history, replication cycle, and pathogenesis of influenza viruses,
the cause of seasonal influenza and of influenza pandemics. and exhaustion, peaking 2–3 days after
infection and resolving within 1–2
weeks.
Serious illness occurs in a minority of
cases, often due to secondary bacterial
infections or exacerbation of
cardiovascular and respiratory illness.
At-risk groups include infants, older
adults, pregnant women, and the
immunocompromised.
The large total number of cases meansInfluenza viruses infect many vertebrates, with Influenza A, B and C viruses (IAV, IBV, and ICV) infecting humans.
High mutation rates allow the evasion of immunity. IAV from different host species can ‘reassort’ their segmented
genomes, producing pandemic strains that are antigenically novel but otherwise well adapted to humans.
The ‘Great Influenza’ pandemic of 1918 remains the worst outbreak of infectious disease in history. There is
concern that highly pathogenic avian influenza viruses of the H5 and H7 subtypes may evolve to cause similar
pandemics.
In humans, influenza viruses infect the respiratory epithelium. The haemagglutinin (HA) proteins of IAV and IBV, or
the haemagglutinin-esterase-fusion (HEF) proteins of ICV, bind sialic acid, causing endocytosis. Unusually
among RNA viruses, the viral genome replicates in the nucleus. New viruses assemble at the cell surface and are
released by the receptor-cleaving neuraminidase (NA) proteins of IAV and IBV or the ICV HEF protein.that seasonal influenza, mainly caused
by IAV and IBV, typically kills 290 000–
650 000 a year globally.
IAV pandemics can be more serious.
The ‘Great Influenza’ of 1918 killed
around 1 in 30 of the global population
in 18 months.
IAV also causes serious illness in
poultry.
Seasonal influenza vaccines are
available but must be regularly
updated.
NA inhibitors can be used for
treatment.
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seasonal strainsTrends in Microbiology, SeptembTAXONOMY AND CLASSIFICATION:
ORDER: Unassigned
FAMILY: Orthomyxoviridae
GENERA (SPECIES): Alphainfluenzavirus (Influenza A virus),
Betainfluenzavirus (Influenza B virus), Gammainfluenzavirus
(Influenza C virus) and Deltainfluenzavirus (Influenza D virus)
can all infect mammals. Distinct influenza viruses of fish
and amphibians have been reported
SUBTYPES AND LINEAGES: based on the major surface
antigens, there are 18 HA (H1–H18) and 11 NA (N1–N11)
subtypes of Influenza A virus and two recent lineages,
‘Victoria’ and ‘Yamagata,’ of Influenza B virus
GENOME: segmented, negative-sense RNA
STRUCTURE: enveloped, pleomorphic (ranging from
spheres to extremely long filaments) with a helical capsidedward.hutchinson@glasgow.ac.uk
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